questionText: To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential obstacles to the Medicines and Healthcare products Regulatory Agency meeting its statutory licensing commitments for clinical trials for the year 2022-
answerText: The Medicines and Healthcare products Regulatory Agency (MHRA) has been transparent about its performance, and since March 2023 has published monthly data indicating the number of clinical trial applications and average timescales for applications to be a...
heading: Medicines and Healthcare products Regulatory Agency: Clinical Trials